Delivery Order SPE2DB22D2206-SPE2DB25FHK36
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for supply of Emverm 100 mg tablet chewable unit dose formulations. This competitively awarded, non-set-aside contract carries a ceiling value of $4,208.18 under a firm fixed price arrangement, with an ultimate completion date of June 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $7,266.59. This competitively awarded, firm fixed-price delivery order is set to conclude by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition based on...
- The Defense Logistics Agency awarded a $11,485.09 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Emverm 100 mg tablet chewables under a firm fixed-price contract. This non-set-aside award was competitively procured and is scheduled for completion by September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $22,395.03 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Emverm 100 mg tablet chewables under a firm fixed-price contract. The contract, which is classified as a child award under a larger indefinite delivery vehicle, requires performance completion by June 20, 2025, with fulfillment at the vendor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded without any set-aside designation,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packaging. This is a firm fixed price delivery order with a ceiling value of $16,635.72 and an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,998.57 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewable units, with a completion date of September 29, 2025. This non-set-aside award was issued on September 26, 2025, with performance to be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units, with a ceiling value of $8,195.85. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This delivery order, awarded on June 24, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, covers the supply of Emverm 100 mg tablet chewables in unit dose strips. The contract is a firm fixed-price delivery order valued at $12,816.21 with a completion date of June 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $2,984.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of issue, with an ultimate completion date of September 3, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the...
- The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHK36Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,214.32 to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Emverm 100 mg tablet chewable units of use. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 12, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC serves as the prime contract vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's extensive portfolio of federal medical procurement demonstrates its capability to meet DLA requirements through open competition, positioning it as a critical vendor for federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 6/11/25 |